1.1.1.146 11beta-hydroxysteroid dehydrogenase macrophage activity occurs after differentiation of neutrophils to macrophages 669730 1.1.1.146 11beta-hydroxysteroid dehydrogenase macrophage derived from bone-marrow, peritoneal macrophages, expression of isozyme 11beta-HSD1, not isozyme 11beta-HSD2 669730 1.1.1.146 11beta-hydroxysteroid dehydrogenase macrophage isoform 11betaHSD2 741066 1.1.1.153 sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming) macrophage - 286017 1.1.1.188 prostaglandin-F synthase macrophage peritoneal 654851 1.1.1.21 aldose reductase macrophage - -, 669503, 738833, 739113 1.1.1.21 aldose reductase macrophage in inflamed temporal arteries 668868 1.1.1.271 GDP-L-fucose synthase macrophage - 667231 1.1.1.49 glucose-6-phosphate dehydrogenase (NADP+) macrophage - 655495 1.11.2.2 myeloperoxidase macrophage - 697307, 700458 1.13.11.11 tryptophan 2,3-dioxygenase macrophage - 743358 1.13.11.31 arachidonate 12-lipoxygenase macrophage - -, 704947, 726846, 741573 1.13.11.31 arachidonate 12-lipoxygenase macrophage 12/15-LOX is a macrophage-selective regulator of interleukin-12 production -, 704003 1.13.11.31 arachidonate 12-lipoxygenase macrophage 12/15-LOX is expressed by 95% of resident peritoneal CD11bhigh cells, with the remaining 5% being 12/15-LOX-. 12/15-LOX+ cells are phenotypically defined by high F4/80, SR-A, and Siglec1 expression, and enhanced IL-10 and G-CSF generation. In contrast, 12/15-LOX- cells are a dendritic cell population. Resident peritoneal macrophage numbers are significantly increased in 12/15-LOX-/- mice, suggesting alterations in migratory trafficking or cell differentiation in vivo -, 704943 1.13.11.31 arachidonate 12-lipoxygenase macrophage macrophages that overexpress 12/15LO have reduced ATP-binding cassette G1 expression, increased transporter phosphorylation, and reduced cholesterol efflux 704567 1.13.11.31 arachidonate 12-lipoxygenase macrophage peritoneal -, 684803 1.13.11.31 arachidonate 12-lipoxygenase macrophage resident peritoneal 742000 1.13.11.33 arachidonate 15-lipoxygenase macrophage - 703628, 742239 1.13.11.33 arachidonate 15-lipoxygenase macrophage 12/15-LOX is a macrophage-selective regulator of interleukin-12 production -, 704003 1.13.11.33 arachidonate 15-lipoxygenase macrophage 12/15-LOX is expressed by 95% of resident peritoneal CD11bhigh cells, with the remaining 5% being 12/15-LOX-. 12/15-LOX+ cells are phenotypically defined by high F4/80, SR-A, and Siglec1 expression, and enhanced IL-10 and G-CSF generation. In contrast, 12/15-LOX- cells are a dendritic cell population. Resident peritoneal macrophage numbers are significantly increased in 12/15-LOX-/- mice, suggesting alterations in migratory trafficking or cell differentiation in vivo -, 704943 1.13.11.33 arachidonate 15-lipoxygenase macrophage alveolar 742613 1.13.11.33 arachidonate 15-lipoxygenase macrophage high level expression in peritoneal macrophages, while murine peripheral monocytes, alveolar macrophages and bone marrow-derived macrophages express alox15 only at low levels 742613 1.13.11.33 arachidonate 15-lipoxygenase macrophage isozyme 15-LO-1, differentiated monocytes obtained from human venous blood, CD14+ 687235 1.13.11.33 arachidonate 15-lipoxygenase macrophage peritoneal -, 684350 1.13.11.33 arachidonate 15-lipoxygenase macrophage resident peritoneal 742000 1.13.11.33 arachidonate 15-lipoxygenase macrophage rheumatoid arthritis tissue 701978 1.13.11.34 arachidonate 5-lipoxygenase macrophage - 660111, 704997, 711100, 713540, 743614 1.13.11.34 arachidonate 5-lipoxygenase macrophage alveolar macrophage 742001 1.13.11.52 indoleamine 2,3-dioxygenase macrophage - 666461, 711952, 743358 1.13.11.52 indoleamine 2,3-dioxygenase macrophage enzyme is induced in monocyte-derived macrophages treated with human recombinant interferon-beta or interferon gamma 395468 1.13.11.52 indoleamine 2,3-dioxygenase macrophage in the villous stroma and in the fetal membrane 659803 1.14.11.29 hypoxia-inducible factor-proline dioxygenase macrophage - 745510 1.14.11.68 [histone H3]-trimethyl-L-lysine27 demethylase macrophage expressed in macrophages in response to bacterial products and inflammatory cytokines 753165 1.14.13.39 nitric-oxide synthase (NADPH) macrophage - -, 440193, 440195, 440198, 440204, 440206, 440207, 440208, 440209, 440219, 440226, 440234, 440236, 674558 1.14.13.39 nitric-oxide synthase (NADPH) macrophage alveolar 690183 1.14.13.39 nitric-oxide synthase (NADPH) macrophage bone marrow-derived 687727 1.14.13.39 nitric-oxide synthase (NADPH) macrophage Ca2+-independent form 440200, 440201 1.14.13.39 nitric-oxide synthase (NADPH) macrophage cytokine-activated 440192, 440200, 440219 1.14.13.39 nitric-oxide synthase (NADPH) macrophage in liver, lung, kidney, isoform II 440226 1.14.13.39 nitric-oxide synthase (NADPH) macrophage inducible enzyme 671728 1.14.13.39 nitric-oxide synthase (NADPH) macrophage iNOS 687358 1.14.13.39 nitric-oxide synthase (NADPH) macrophage iNOS is the predominant isozyme in macrophages 695853 1.14.13.39 nitric-oxide synthase (NADPH) macrophage NOS2 701646 1.14.13.39 nitric-oxide synthase (NADPH) macrophage RAW 264.7 cells 440219, 440221, 440222, 440223, 440225, 440236, 440238 1.14.13.9 kynurenine 3-monooxygenase macrophage - 763915, 764034 1.14.13.9 kynurenine 3-monooxygenase macrophage in first and second trimester of the placenta, within the fetal villus 660112 1.14.14.18 heme oxygenase (biliverdin-producing) macrophage - 684920, 685498, 686078, 688061, 688881, 705614, 733904 1.14.14.18 heme oxygenase (biliverdin-producing) macrophage peritoneal, alveolar 438244 1.14.14.29 25/26-hydroxycholesterol 7alpha-hydroxylase macrophage bone marrow-derived 699414 1.14.15.15 cholestanetriol 26-monooxygenase macrophage - 703582 1.14.15.18 calcidiol 1-monooxygenase macrophage - 675057, 675686 1.14.15.18 calcidiol 1-monooxygenase macrophage expression of 1alpha-hydroxylase is intimately associated with toll-like receptor, TLR, recognition of pathogens in macrophages 712885 1.14.15.18 calcidiol 1-monooxygenase macrophage monocyte-derived 688675 1.14.16.5 alkylglycerol monooxygenase macrophage - 746303 1.14.99.38 cholesterol 25-monooxygenase macrophage - -, 699414, 700999, 715833, 744738 1.14.99.38 cholesterol 25-monooxygenase macrophage testicular 658244, 658246 1.14.99.38 cholesterol 25-monooxygenase macrophage testicular, 10-day-old animals have the highest steady-state levels of message 658245 1.15.1.1 superoxide dismutase macrophage - 685864 1.15.1.1 superoxide dismutase macrophage peritoneal macrophages exposed to He-Ne laser radiation. Changes in the activity of superoxide dismutase as well as the formation of nitric oxide and peroxynitrite depend to a large extent on the laser radiation dose. Activation of enzyme at low radiation doses is accompanied by nitric oxide level increase without changes in peroxynitrite. Enhanced laser radiation doses inhibit the enzyme 672292 1.16.3.1 ferroxidase macrophage - 438021 1.17.3.2 xanthine oxidase macrophage alveolar macrophages purified from the lung by lavage, and interstitial macrophages. Inflammatory cells express high levels of XOR activity, while in resident alveolar macrophage the enzyme content is extremely low prior to cytokine insufflation -, 715663 1.2.1.104 pyruvate dehydrogenase system macrophage - 763502 1.2.1.13 glyceraldehyde-3-phosphate dehydrogenase (NADP+) (phosphorylating) macrophage peritoneal 288005 1.2.1.36 retinal dehydrogenase macrophage hepatic 743375 1.2.4.1 pyruvate dehydrogenase (acetyl-transferring) macrophage - 763502 1.3.1.21 7-dehydrocholesterol reductase macrophage - 763129 1.3.1.24 biliverdin reductase macrophage - 673797, 698922, 740486, 740549 1.3.1.24 biliverdin reductase macrophage increased expression in macrophages of primary spontaneous pneumothorax of smokers compared to non-smokers 713359 1.3.1.24 biliverdin reductase macrophage lung 713359 1.4.3.2 L-amino-acid oxidase macrophage - 726320 1.4.3.2 L-amino-acid oxidase macrophage immunostaining in macrophages associated with non small-cell lung carcinomas, mesotheliomas, colorectal carcinomas and testicular germ cell tumors, positive staining in germinal centers of reactive lymph nodes and hyperplastic tonsils, and in the spleen 699933 1.5.3.16 spermine oxidase macrophage - 725128, 741582 1.6.1.2 NAD(P)+ transhydrogenase (Re/Si-specific) macrophage bone marrow-derived, Nnt mRNA and protein are expressed in resting macrophages and down-regulated in response to inflammatory stimuli such as lipopolysaccharide. Nnt mRNA and protein expression are further repressed in fully activated macrophages 724953 1.6.1.2 NAD(P)+ transhydrogenase (Re/Si-specific) macrophage bone marrow-derived, Nnt mRNA and protein are expressed in resting macrophages and down-regulated in response to inflammatory stimuli such as lipopolysaccharide. Nnt mRNA and protein expression are repressed in fully activated macrophages 724953 1.6.3.1 NAD(P)H oxidase (H2O2-forming) macrophage - 742310, 743287 1.6.3.1 NAD(P)H oxidase (H2O2-forming) macrophage alveolar macrophages. Inhibition of NAD(P)H oxidase by apocynin results in down-regulation of arginase 686562 1.6.3.1 NAD(P)H oxidase (H2O2-forming) macrophage Burkholderia cenocepacia resides in macrophage vacuoles displaying an altered recruitment of the NADPH oxidase complex at the phagosomal membrane 700052 1.6.3.1 NAD(P)H oxidase (H2O2-forming) macrophage isoforms NOX2 and NOX4 742567 1.6.5.2 NAD(P)H dehydrogenase (quinone) macrophage enzyme is highly upregulated in active and chronic multiple sclerosis lesions, particularly in hypertrophic astrocytes and myelin-laden macrophages 673798 1.8.1.7 glutathione-disulfide reductase macrophage - 690144 1.8.4.12 peptide-methionine (R)-S-oxide reductase macrophage highly expressed in immune-activated macrophages 765804 1.8.4.2 protein-disulfide reductase (glutathione) macrophage - 394863 2.1.1.319 type I protein arginine methyltransferase macrophage - 756732 2.1.1.355 [histone H3]-lysine9 N-trimethyltransferase macrophage - 755432 2.1.1.360 [histone H3]-lysine79 N-trimethyltransferase macrophage - 753191 2.1.1.364 [histone H3]-lysine4 N-methyltransferase macrophage - 704436 2.1.1.366 [histone H3]-N6,N6-dimethyl-lysine9 N-methyltransferase macrophage - 755432 2.1.1.63 methylated-DNA-[protein]-cysteine S-methyltransferase macrophage - 701644 2.2.1.1 transketolase macrophage at the lesion border 694176 2.3.1.147 glycerophospholipid arachidonoyl-transferase (CoA-independent) macrophage - 16268 2.3.1.148 glycerophospholipid acyltransferase (CoA-dependent) macrophage - 16278 2.3.1.15 glycerol-3-phosphate 1-O-acyltransferase macrophage bone marrow-derived macrophages -, 756014 2.3.1.23 1-acylglycerophosphocholine O-acyltransferase macrophage - 704461, 736546, 756102 2.3.1.23 1-acylglycerophosphocholine O-acyltransferase macrophage primary peripheral blood macrophages 735571 2.3.1.26 sterol O-acyltransferase macrophage - 486696, 486703, 684800, 702552, 702650, 703975, 736792 2.3.1.26 sterol O-acyltransferase macrophage ACAT1, villus 486708 2.3.1.26 sterol O-acyltransferase macrophage loss of ACAT activity in macrophages, either by pharmacological inhibition or by genetic knockout of ACAT-1, results in reduced induction of apoptosis in response to 7-ketocholesterol or oxidized low density lipoproteins. The apoptotic signal generated in macrophages by ACAT may be an arachidonyl oxysterol 675261 2.3.1.26 sterol O-acyltransferase macrophage monocyte-derived macrophage 684780 2.3.1.26 sterol O-acyltransferase macrophage relative high level of mRNA 486703 2.3.1.48 histone acetyltransferase macrophage - -, 702855 2.3.1.50 serine C-palmitoyltransferase macrophage alveolar 702430 2.3.1.50 serine C-palmitoyltransferase macrophage bone marrow–derived 736559 2.3.1.50 serine C-palmitoyltransferase macrophage mucosal from colon, lung, prostate, stomach, thyroid, uterus, vascular tissue 487177 2.3.1.67 1-alkylglycerophosphocholine O-acetyltransferase macrophage - 736604 2.3.1.67 1-alkylglycerophosphocholine O-acetyltransferase macrophage bone marrow-derived 735644 2.3.1.97 glycylpeptide N-tetradecanoyltransferase macrophage - 719244 2.3.1.97 glycylpeptide N-tetradecanoyltransferase macrophage alveolar 703591 2.3.1.97 glycylpeptide N-tetradecanoyltransferase macrophage intravascular, high NMT1 expression 706890 2.3.1.B43 protein-lysine desuccinylase (NAD+) macrophage SIRT5 and SIRT1/2 have opposite expression patterns and functions in macrophages, overview 757084 2.3.2.13 protein-glutamine gamma-glutamyltransferase macrophage - 487830, 759544 2.3.2.13 protein-glutamine gamma-glutamyltransferase macrophage monocyte-derived, presence of large amounts of TG2 on cell surface 703983 2.3.2.2 gamma-glutamyltransferase macrophage - 736220 2.3.2.25 N-terminal E2 ubiquitin-conjugating enzyme macrophage - 759122 2.3.3.8 ATP citrate synthase macrophage - 735597 2.4.1.133 xylosylprotein 4-beta-galactosyltransferase macrophage in the lesion site after spinal cord injury 704802 2.4.1.212 hyaluronan synthase macrophage HAS1 expression is shown in 55.7% of SIRPA-positive macrophages in stage III follicles 702525 2.4.1.274 glucosylceramide beta-1,4-galactosyltransferase macrophage alveolar mactrophage 759227 2.4.1.38 beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase macrophage high expression level 687078 2.4.1.66 procollagen glucosyltransferase macrophage peritoneal 439149 2.4.1.80 ceramide glucosyltransferase macrophage - 706799 2.4.1.87 N-acetyllactosaminide 3-alpha-galactosyltransferase macrophage - 489469 2.4.2.12 nicotinamide phosphoribosyltransferase macrophage - 722182, 735872 2.4.2.31 NAD+-protein-arginine ADP-ribosyltransferase macrophage - 672357 2.4.2.4 thymidine phosphorylase macrophage - 638468 2.4.2.4 thymidine phosphorylase macrophage very high expression level 705495 2.4.3.1 beta-galactoside alpha-(2,6)-sialyltransferase macrophage - 722730 2.4.3.9 lactosylceramide alpha-2,3-sialyltransferase macrophage - 657703 2.4.3.9 lactosylceramide alpha-2,3-sialyltransferase macrophage differentiated monocyte-derived macrophages 705676 2.4.3.9 lactosylceramide alpha-2,3-sialyltransferase macrophage excessive GM3 is synthesized in atherosclerotic lesions by macrophages and dendritic cells directly within the arterial walls 657703 2.6.1.42 branched-chain-amino-acid transaminase macrophage - 758657 2.7.1.1 hexokinase macrophage - 737993 2.7.1.107 diacylglycerol kinase (ATP) macrophage - 675157 2.7.1.107 diacylglycerol kinase (ATP) macrophage alveolar, isozymes DGKalpha and DGKzeta 660679 2.7.1.134 inositol-tetrakisphosphate 1-kinase macrophage bone marrow 640814 2.7.1.137 phosphatidylinositol 3-kinase macrophage the regulatory subunit p87PIKAP and the catalytic subunit p101 are both expressed 674783 2.7.1.138 ceramide kinase macrophage - -, 738824 2.7.1.138 ceramide kinase macrophage bone marrow-derived macrophage, BMDM 693223, 693454 2.7.1.153 phosphatidylinositol-4,5-bisphosphate 3-kinase macrophage - 709350, 709980, 710351 2.7.1.153 phosphatidylinositol-4,5-bisphosphate 3-kinase macrophage bone marrow-derived macrophages 722219 2.7.1.154 phosphatidylinositol-4-phosphate 3-kinase macrophage cell culture 645036 2.7.1.154 phosphatidylinositol-4-phosphate 3-kinase macrophage cell culture, cell line J774.2 645036 2.7.1.154 phosphatidylinositol-4-phosphate 3-kinase macrophage dermal, moderate expression of PI3K-C2alpha and PI3K-C2beta 645046 2.7.1.154 phosphatidylinositol-4-phosphate 3-kinase macrophage glomerular, moderate expression of PI3K-C2beta 645046 2.7.1.154 phosphatidylinositol-4-phosphate 3-kinase macrophage isozyme PI3K-C2beta 645046 2.7.1.154 phosphatidylinositol-4-phosphate 3-kinase macrophage PI3K-C2alpha and PI3K-C2beta 645046 2.7.1.91 sphingosine kinase macrophage - 674843 2.7.1.91 sphingosine kinase macrophage from bone marrow. N,N-dimethyl-D-erythro-sphingosine inhibits osteoclastogenesis a sphingosine kinase independently of sphingosine kinase 689070 2.7.10.1 receptor protein-tyrosine kinase macrophage - 660727 2.7.10.1 receptor protein-tyrosine kinase macrophage BAC1.2F5 macrophage cell line 490192 2.7.10.1 receptor protein-tyrosine kinase macrophage Ron is expressed on alveolar and peritoneal and monocyte-derived macrophages 690303 2.7.10.2 non-specific protein-tyrosine kinase macrophage - 490151, 671253, 672781, 675097, 691455, 692647 2.7.10.2 non-specific protein-tyrosine kinase macrophage from bone marrow 662575 2.7.10.2 non-specific protein-tyrosine kinase macrophage peritoneal and alveolar 675097 2.7.10.2 non-specific protein-tyrosine kinase macrophage peritoneal and splenic, and bone-marrow macrophages -, 675204 2.7.11.1 non-specific serine/threonine protein kinase macrophage - 742344 2.7.11.10 IkappaB kinase macrophage - 662570, 671920, 704912 2.7.11.10 IkappaB kinase macrophage activated macrophages are significantly increased in Helicobacter pylori-infected gastric mucosa and are identified as being important cells with potent activation of NF-kappaB, which plays an important part in producing proinflammatory cytokines. Macrophage depletion by the administration of clodronate resulted in milder inflammation in gerbils infected with Helicobacter pylori 692604 2.7.11.10 IkappaB kinase macrophage alveolar and peritoneal 662945 2.7.11.10 IkappaB kinase macrophage bone marrow-derived or RAW-264.7 macrophages 723569 2.7.11.15 beta-adrenergic-receptor kinase macrophage - -, 673187 2.7.11.15 beta-adrenergic-receptor kinase macrophage peritoneal macrophages, activation of Toll-like receptors significantly increases GRK2 expression in primary macrophages, mechanism, overview -, 689035 2.7.11.16 G-protein-coupled receptor kinase macrophage - 674691 2.7.11.16 G-protein-coupled receptor kinase macrophage peritoneal macrophages, activation of Toll-like receptors selectively decreases arrestin-2 and GRK5 protein level in primary macrophages, mechanism, overview -, 689035 2.7.11.16 G-protein-coupled receptor kinase macrophage peritoneal macrophages, activation of Toll-like receptors selectively decreases arrestin-2 and GRK6 protein level in primary macrophages, mechanism, overview -, 689035 2.7.11.21 polo kinase macrophage transition of monocytes from peripheral blood to matrix bound macrophages is accompanied by increasing levels of Fnk with time in culture 491303 2.7.11.24 mitogen-activated protein kinase macrophage - 491714, 664279, 681966, 691878 2.7.11.24 mitogen-activated protein kinase macrophage p38 MAPK 665798 2.7.11.25 mitogen-activated protein kinase kinase kinase macrophage - 663773 2.7.11.25 mitogen-activated protein kinase kinase kinase macrophage TPL-2 and MEKK1 682954 2.7.11.30 receptor protein serine/threonine kinase macrophage - 762408 2.7.11.31 [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase macrophage - 760351 2.7.11.31 [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase macrophage bone marrow-derived -, 739863 2.7.12.1 dual-specificity kinase macrophage - 761772 2.7.12.2 mitogen-activated protein kinase kinase macrophage - 491932, 663773 2.7.4.14 UMP/CMP kinase macrophage - 645160, 693063 2.7.4.21 inositol-hexakisphosphate 5-kinase macrophage - -, 737654 2.7.7.15 choline-phosphate cytidylyltransferase macrophage BAC1.2F5 cell line, SCF-1-dependent clone derived from the BAC1 line which originated from transfection of splenic adherent cells with SV40 642911 2.7.7.15 choline-phosphate cytidylyltransferase macrophage CCTalpha is the major CCT isoform in macrophages 691467 2.7.7.30 fucose-1-phosphate guanylyltransferase macrophage - 667231 2.7.7.86 cyclic GMP-AMP synthase macrophage - 738006 2.7.7.86 cyclic GMP-AMP synthase macrophage primary and immortalized murine macrophages 738791 2.7.7.96 ADP-D-ribose pyrophosphorylase macrophage - 684834 2.7.8.2 diacylglycerol cholinephosphotransferase macrophage bacillus Calmette-Guerin induced rabbit 644341 2.7.8.27 sphingomyelin synthase macrophage - 690656, 708149, 760628 2.7.8.27 sphingomyelin synthase macrophage SMS1 is the major SMS 737844 2.7.9.1 pyruvate, phosphate dikinase macrophage - -, 738533 2.8.1.7 cysteine desulfurase macrophage enzyme isoform Nfs1 671626 2.8.1.7 cysteine desulfurase macrophage mitochondrial isoform of Nfs1 671626 2.8.2.29 [heparan sulfate]-glucosamine 3-sulfotransferase 2 macrophage primary macrophages. HS3ST2 is highly expressed in non-activated macrophages 760623 2.8.2.30 [heparan sulfate]-glucosamine 3-sulfotransferase 3 macrophage primary macrophages. HS3ST3B is highly expressed in activated macrophages, highest after alternative stimulation (M2 polarization), while the enzyme is not detected in proinflammatory macrophages (M1) 760623 2.8.2.4 estrone sulfotransferase macrophage high expression 723909 2.8.2.8 [heparan sulfate]-glucosamine N-sulfotransferase macrophage high expression level of isozyme NDST2 704666 3.1.1.1 carboxylesterase macrophage - 691075 3.1.1.1 carboxylesterase macrophage CES1, no expression of CES2 707570 3.1.1.111 phosphatidylserine sn-1 acylhydrolase macrophage THP-1-derived macrophage 753210 3.1.1.116 sn-1-specific diacylglycerol lipase macrophage peritoneal macrophages 761970 3.1.1.13 sterol esterase macrophage - 665963, 677459, 681075, 715834 3.1.1.13 sterol esterase macrophage expressed at high levels in macrophages 693179 3.1.1.13 sterol esterase macrophage expressed at high levels in peritoneal macrophages 693179 3.1.1.13 sterol esterase macrophage highly expressed in macrophages 715324 3.1.1.13 sterol esterase macrophage J774 A.1 cells 133832 3.1.1.13 sterol esterase macrophage NCEH1 is expressed in CD68-positive macrophage foam cells of human atherosclerotic lesions 714756 3.1.1.2 arylesterase macrophage - 692438 3.1.1.23 acylglycerol lipase macrophage - 751669 3.1.1.25 1,4-lactonase macrophage - 692438 3.1.1.3 triacylglycerol lipase macrophage - 664561, 707547, 729337, 729345 3.1.1.32 phospholipase A1 macrophage - 690664, 94310 3.1.1.34 lipoprotein lipase macrophage - -, 652702, 664174, 693516, 708067, 729306, 750657 3.1.1.4 phospholipase A2 macrophage - 681856, 691109 3.1.1.4 phospholipase A2 macrophage GIVA PLA2 and GVIA PLA2 709421 3.1.1.4 phospholipase A2 macrophage group V sPLA2 691654 3.1.1.4 phospholipase A2 macrophage primary lung macrophage 707726 3.1.1.4 phospholipase A2 macrophage primary lung macrophage, cPLA2-alpha and iPLA2. Contains the following sPLA2s: GXIIA, GIID, GIIE, GIIF, GX and GIIA. Only GX appears to be released to a limited extent. GIIE and GIIF are only present at the protein level and not on the mRNA level 707554 3.1.1.47 1-alkyl-2-acetylglycerophosphocholine esterase macrophage - 650339, 652685, 678390, 690321, 690322, 690673, 691653, 691929, 693526 3.1.1.47 1-alkyl-2-acetylglycerophosphocholine esterase macrophage decidual and monocyte-derived 650326 3.1.1.47 1-alkyl-2-acetylglycerophosphocholine esterase macrophage increased enzyme expression in artheriosclerosis 650932 3.1.1.47 1-alkyl-2-acetylglycerophosphocholine esterase macrophage no significant modifications of pPAF-AH mRNA in macrophages or in ApoB100 values is observed in hepatitis C virus patients compared with controls 681670 3.1.1.47 1-alkyl-2-acetylglycerophosphocholine esterase macrophage peritoneal 650326 3.1.1.47 1-alkyl-2-acetylglycerophosphocholine esterase macrophage resident ones of the liver, and peritoneal 652009 3.1.1.47 1-alkyl-2-acetylglycerophosphocholine esterase macrophage secretion 649802 3.1.1.47 1-alkyl-2-acetylglycerophosphocholine esterase macrophage secretion of plasma isozyme after cleavage of the signal peptide at Ala17/Val18, high enzyme activity during differentiation of monocytes to macrophages 653695 3.1.1.52 phosphatidylinositol deacylase macrophage - 80968 3.1.1.77 acyloxyacyl hydrolase macrophage - 246553 3.1.1.79 hormone-sensitive lipase macrophage - 646087, 654152, 655309, 730333 3.1.2.2 palmitoyl-CoA hydrolase macrophage up-regulated by lipopolysaccharide and that overexpression of Acot7 in a macrophage cell line alters the production of prostaglandins D2 and E2 682542 3.1.22.1 deoxyribonuclease II macrophage - 134281, 653890 3.1.22.1 deoxyribonuclease II macrophage CD68-positive macrophage 730727 3.1.3.16 protein-serine/threonine phosphatase macrophage - 692321 3.1.3.2 acid phosphatase macrophage - 134784, 652665, 666100, 679089 3.1.3.2 acid phosphatase macrophage isozyme 5a, secretion 665956 3.1.3.36 phosphoinositide 5-phosphatase macrophage murine RAW264.7 macrophages are used 691699 3.1.3.4 phosphatidate phosphatase macrophage - 691109 3.1.3.48 protein-tyrosine-phosphatase macrophage bone-marrow-derived 709416 3.1.3.67 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase macrophage - 694494 3.1.3.9 glucose-6-phosphatase macrophage - 134923, 134925 3.1.4.1 phosphodiesterase I macrophage - -, 208380, 730060 3.1.4.11 phosphoinositide phospholipase C macrophage M1, M2 and unpolarized M0 macrophages 751177 3.1.4.12 sphingomyelin phosphodiesterase macrophage - 691696, 714052, 730060 3.1.4.12 sphingomyelin phosphodiesterase macrophage peritoneal 680143 3.1.4.3 phospholipase C macrophage alveolar macrophage 677502 3.1.4.3 phospholipase C macrophage monocyte-derived macrophage, enzyme is activated by HIV-1 R5 gp120 interaction with CCR5 and is required for NF-kB-mediated chemokine CCL2 production triggered by R5 gp120 678920 3.1.4.4 phospholipase D macrophage - 708072 3.1.4.4 phospholipase D macrophage adhesion of primary neutrophils and monocyte-derived macrohages to fibronectin is accompanied by marked stimulation of enzyme activity. Similarly, adhesion of myeloid-macrophage cell lines to fibronectin, collagen, or plastic results in significant activation. Stimulation of enzyme is rapid and persists for at least 90 min 681193 3.1.4.53 3',5'-cyclic-AMP phosphodiesterase macrophage PDE4B. Ablation of PDE4B partially protects mice from LPS-induced shock 669723 3.1.5.B1 dNTPase macrophage - 752156 3.1.6.1 arylsulfatase (type I) macrophage - 709806 3.10.1.1 N-sulfoglucosamine sulfohydrolase macrophage highly vacuolated 689776 3.2.1.14 chitinase macrophage alternatively activated, lysosomes and endosomes 664449 3.2.1.14 chitinase macrophage the enzyme is expressed and secreted in high quantities by lipid-laden tissue macrophages in Gaucher patients 729540 3.2.1.166 heparanase macrophage - -, 731626, 732437, 753404, 755259 3.2.1.17 lysozyme macrophage - 717466 3.2.1.17 lysozyme macrophage alveolar 171055 3.2.1.17 lysozyme macrophage contains c-type and g-type lysozymes 729618 3.2.1.18 exo-alpha-sialidase macrophage - 704674 3.2.1.207 mannosyl-oligosaccharide alpha-1,3-glucosidase macrophage - 743920 3.2.1.52 beta-N-acetylhexosaminidase macrophage the importance of beta-hexosaminidase for restricting mycobacterial growth during mammalian infections is confirmed in macrophages from beta-hexosaminidase knockout mice. beta-Hexosaminidase is characterized as a peptidoglycan hydrolase that exerts its mycobactericidal effect at the macrophage plasma membrane during mycobacteria-induced secretion of lysosomes 682592 3.2.2.27 uracil-DNA glycosylase macrophage - 694122 3.2.2.5 NAD+ glycohydrolase macrophage from bone marrow. Tumor necrosis factor alpha upregulates CD38. Induced CD38 expression enhances inflammatory gene expression by decreasing ERK1/2 phosphorylation and increasing NF kappaB activation. It negatively affects the expression of osteoclast markers. CD38 may reduce osteoclastogenesis and increase inflammatory gene induction by decreasing cellular histone deacetylase activity 683052 3.3.2.10 soluble epoxide hydrolase macrophage - 707076 3.3.2.6 leukotriene-A4 hydrolase macrophage - 753500 3.3.2.6 leukotriene-A4 hydrolase macrophage alveolar macrophage 647024 3.3.2.9 microsomal epoxide hydrolase macrophage alveolar 753726 3.4.11.2 membrane alanyl aminopeptidase macrophage - 663607, 666240 3.4.11.2 membrane alanyl aminopeptidase macrophage high enzyme expression, of percardial fluid 665244 3.4.14.2 dipeptidyl-peptidase II macrophage - 95234 3.4.14.2 dipeptidyl-peptidase II macrophage alveolar macrophages 95243 3.4.14.2 dipeptidyl-peptidase II macrophage low activity, alveolar, myometrical and of the red pulp 650796 3.4.14.5 dipeptidyl-peptidase IV macrophage - 649282, 695514 3.4.14.9 tripeptidyl-peptidase I macrophage - 664560, 697743 3.4.15.1 peptidyl-dipeptidase A macrophage - 81241 3.4.15.1 peptidyl-dipeptidase A macrophage mice with expression of angiotensin convertzing enzyme only in monocytes and macrophages have a marked resistance to the growth of melanoma due to an enhanced immune response 680175 3.4.16.2 lysosomal Pro-Xaa carboxypeptidase macrophage - 36268 3.4.16.2 lysosomal Pro-Xaa carboxypeptidase macrophage alveolar 36273 3.4.16.5 carboxypeptidase C macrophage of lung 665905 3.4.17.1 carboxypeptidase A macrophage in primary macrophages, CPVL is glycosylated with high mannose residues 687160 3.4.17.12 carboxypeptidase M macrophage - 670291 3.4.17.12 carboxypeptidase M macrophage CPM expression is the highest in macrophages 697395 3.4.17.20 Carboxypeptidase U macrophage - 670940 3.4.17.22 metallocarboxypeptidase D macrophage - 683703 3.4.17.23 angiotensin-converting enzyme 2 macrophage - 679704, 681180, 708649 3.4.18.1 cathepsin X macrophage - 708023 3.4.18.1 cathepsin X macrophage tumor-associated 679023 3.4.19.12 ubiquitinyl hydrolase 1 macrophage expression level of CYLD is extremely low 699177 3.4.19.3 pyroglutamyl-peptidase I macrophage - 680172 3.4.21.106 hepsin macrophage - 718105 3.4.21.109 matriptase macrophage - 683489, 695463, 698077 3.4.21.20 cathepsin G macrophage - 653667, 731354 3.4.21.26 prolyl oligopeptidase macrophage - 683374, 717073, 81328 3.4.21.26 prolyl oligopeptidase macrophage resident and elicited macrophage 667550 3.4.21.35 tissue kallikrein macrophage - 669519, 731671 3.4.21.37 leukocyte elastase macrophage - 707071 3.4.21.53 Endopeptidase La macrophage - 752805 3.4.21.6 coagulation factor Xa macrophage high expression level in bronchoalveolar lavage fluid macrophages from asthmatic mice 683057 3.4.21.6 coagulation factor Xa macrophage peritoneal 653968 3.4.21.69 Protein C (activated) macrophage - 752736, 753066 3.4.21.7 plasmin macrophage plasmin triggers expression and release of proinflammatory cytokines such as TNF-alpha and IL-6 in human monocyte-derived macrophages with a somewhat lower potency than the standard stimulus lipopolysaccharide. Plasmin-induced activation of JAK1, p38, ERK1/2, and NF-kappaB is indispensable for the cytokine expression 684778 3.4.21.73 u-Plasminogen activator macrophage - -, 683623, 683741, 707951 3.4.21.73 u-Plasminogen activator macrophage blood monocyte-derived 709736 3.4.21.73 u-Plasminogen activator macrophage enzyme expression in atherosclerotic lesion macrophages -, 731237 3.4.21.73 u-Plasminogen activator macrophage from bone-marrow 683623 3.4.21.75 Furin macrophage - 699309 3.4.21.79 granzyme B macrophage - -, 679007, 731617, 754761 3.4.21.79 granzyme B macrophage activated macrophages 709759 3.4.21.93 Proprotein convertase 1 macrophage - 732724 3.4.21.B1 hyaluronan-binding serine protease macrophage - 690121 3.4.21.B1 hyaluronan-binding serine protease macrophage highly expressed in macrophages of atherosclerotic lesions 684801 3.4.21.B24 proprotein convertase 4 macrophage ovarian 707011 3.4.21.B26 proprotein convertase 5 macrophage - 675490 3.4.21.B4 granzyme K macrophage granzyme K is expressed and secreted by cultured classically activated macrophages 754357 3.4.22.1 cathepsin B macrophage - 679023, 709347 3.4.22.1 cathepsin B macrophage bone marrow-derived -, 709116 3.4.22.1 cathepsin B macrophage from bone marrow -, 699337 3.4.22.15 cathepsin L macrophage - 647915, 652657, 652659 3.4.22.15 cathepsin L macrophage the maturation of cathepsin L is impaired in bone marrow-derived macrophages infected with Mycobacterium avium or Mycobacterium tuberculosis 668959 3.4.22.16 cathepsin H macrophage - 638817 3.4.22.16 cathepsin H macrophage 158-298 ng /1000000 cells, distribution in tissues and peripheral blood cells 638823 3.4.22.27 cathepsin S macrophage - 667984, 668394, 668898, 679696, 680995, 682236, 695946, 696630, 696638, 696641, 696743, 697361, 698859, 699142, 699442, 701151, 701183, 753968 3.4.22.27 cathepsin S macrophage cathepsin S is expressed by macrophages infiltrating the human kidney 753981 3.4.22.27 cathepsin S macrophage secreted during prostate cancer progression 707959 3.4.22.34 Legumain macrophage - 731409 3.4.22.34 Legumain macrophage M-CSF differentiated primary macrophages, in vitro expression, also detected in the culture media 683113 3.4.22.34 Legumain macrophage of atherosclerotic aorta of aging Apolipoprotein E deficient mice, mRNA expression increases with development of atherosclerosis 683113 3.4.22.36 caspase-1 macrophage - -, 679079, 681017, 681030, 697733, 698235, 700198, 700362, 700983, 708709, 708712, 717941, 718077 3.4.22.36 caspase-1 macrophage bone marrow derived. Anthrax lethal toxin and Salmonella elicit the common cell death pathway of caspase-1-dependent pyroptosis via distinct mechanisms. Activation of caspase-1 by Bacillus anthracis lethal toxin requires binding, uptake, and endosome acidification to mediate translocation of lethal factor into the host cell cytosol. Catalytically active lethal factor cleaves cytosolic substrates and activates caspase-1 by a mechanism involving proteasome activity and potassium efflux. Lethal toxin activation of caspase-1 requires the inflammasome adapter Nalp1. Salmonella infection activates caspase-1 through an independent pathway requiring the inflammasome adapter Ipaf. These distinct mechanisms of caspase-1 activation converge on a common pathway of caspase-1-dependent cell death featuring DNA cleavage, cytokine activation, and, ultimately, cell lysis resulting from the formation of membrane pores between 1.1 and 2.4 nm in diameter and pathological ion fluxes that can be blocked by glycine 682588 3.4.22.36 caspase-1 macrophage bone marrow-derived -, 698251, 699349 3.4.22.36 caspase-1 macrophage bone marrow-derived macrophage, BMDM cell -, 697199, 698245 3.4.22.36 caspase-1 macrophage bone marrow-derived macrophages, wild-type and superoxide dismutase-deficient 700365 3.4.22.36 caspase-1 macrophage bone-marrow derived 670356 3.4.22.36 caspase-1 macrophage bone-marrow-derived 700393 3.4.22.36 caspase-1 macrophage caspase-1-mediated macrophage necrosis is the source of the cytokine storm and rapid disease progression in anthrax lethal toxin-treated BALB/c mice 679097 3.4.22.36 caspase-1 macrophage IFN regulatory factor IRF-2(-/-) macrophages exhibit increased basal and gliotoxin-induced caspase-1 mRNA expression and enhanced caspase-1 activity 681202 3.4.22.36 caspase-1 macrophage inactive 45000 Da proform of caspase-1 is basally expressed in macrophages, virus infection induces the cleavage of procaspase into the mature 20000 Da form 647636 3.4.22.36 caspase-1 macrophage macrophage-like J774.1 cells 701307 3.4.22.36 caspase-1 macrophage peritoneal 698242 3.4.22.36 caspase-1 macrophage the Gram-negative bacterium Shigella flexneri triggers pro-inflammatory apoptotic cell death in macrophages, which is crucial for the onset of an acute inflammatory diarrhoea termed bacillary dysentery. The Mxi-Spa type III secretion system promotes bacterial uptake and escape into the cytoplasm, where, dependent on the translocator/effector protein IpaB, caspase-1 and its substrate IL-1b are activated 681799 3.4.22.36 caspase-1 macrophage wild-type and TLR4 knockout macrophage 699326 3.4.22.38 cathepsin K macrophage - 707120, 708260, 708450, 708572 3.4.22.38 cathepsin K macrophage alveolar -, 701180 3.4.22.38 cathepsin K macrophage peritoneal 695943 3.4.22.41 cathepsin F macrophage alveolar 137264 3.4.22.41 cathepsin F macrophage derived from cultured monocytes 683112 3.4.22.41 cathepsin F macrophage monocyte-derived cell culture, enzyme is secreted 669249 3.4.22.43 cathepsin V macrophage - 732502 3.4.22.43 cathepsin V macrophage in plaque areas of diseased blood vessels, cathepsin expression levels during differentiation, overview 669257 3.4.22.51 cruzipain macrophage studies are carried out using murine macrophage cell line J774 as well as bone marrow-derived macrophages from BALB/c mice 677418 3.4.22.52 calpain-1 macrophage - 708717 3.4.22.53 calpain-2 macrophage - 717847 3.4.22.56 caspase-3 macrophage from arteriosclerotic carotid artery, presence of proapoptotic markers such as enzyme, poly(ADP-ribose) polymerase, apoptosis-inducing factor, c-Jun/AP-1, and proinflammatory markers such as macrophage migration inhibitory factor and cyclooxygenase-2. Colocalization of proapoptic markers and proinflammatory markers and oxidized low-density lipoproteins 668206 3.4.22.56 caspase-3 macrophage inactive 32000 Da proform of caspase-3 is basally expressed in macrophages, virus infection induces the cleavage of procaspase into the mature 17000 Da form 647636 3.4.22.56 caspase-3 macrophage leukaemia myeloid 697769 3.4.22.56 caspase-3 macrophage peritoneal 698258 3.4.22.57 caspase-4 macrophage - 754851 3.4.22.59 caspase-6 macrophage - 754137 3.4.22.60 caspase-7 macrophage - 732797 3.4.22.60 caspase-7 macrophage bone marrow macrophages prepared from femurs of five to eight-week-old mice -, 700916 3.4.22.61 caspase-8 macrophage - 710388 3.4.22.61 caspase-8 macrophage peritoneal 698258 3.4.22.64 caspase-11 macrophage - 698218, 699327, 731744, 731905 3.4.22.64 caspase-11 macrophage bone marrow-derived -, 718162 3.4.22.B26 calpain 6 macrophage - 754258 3.4.22.B74 SENP6 peptidase macrophage - 752453 3.4.23.34 cathepsin E macrophage - 677973, 679774 3.4.23.34 cathepsin E macrophage derived from mouse bone marrow precursors 681209 3.4.23.34 cathepsin E macrophage mature form of CE in the endosomal structure 678531 3.4.23.5 cathepsin D macrophage - 35013, 711855, 718306 3.4.23.5 cathepsin D macrophage comparative transcriptome analysis is carried out in cholesterol-loaded monocyte-derived macrophages from low high density lipoprotein cholesterol (HDL-C) patients and control group: expression of CTSD is reduced by 50% in monocyte-derived macrophages of low HDL subjects, most significantly those with cholesterol efflux defects but without mutation in ABCA1 groups as compared with controls 680732 3.4.23.5 cathepsin D macrophage peritoneal 36915 3.4.24.14 procollagen N-endopeptidase macrophage - 754590 3.4.24.14 procollagen N-endopeptidase macrophage enzyme expression 734611 3.4.24.14 procollagen N-endopeptidase macrophage enzyme expression, overexpression by macrophages and peripheral blood monocytes stimulated by glucocorticoids 734611 3.4.24.17 stromelysin 1 macrophage - -, 733946 3.4.24.22 stromelysin 2 macrophage - 708422 3.4.24.22 stromelysin 2 macrophage bone marrow-derived and alveolar 753928 3.4.24.22 stromelysin 2 macrophage isolated resident alveolar and bone marrow-derived macrophages (BMDM) -, 754327 3.4.24.23 matrilysin macrophage - 683356 3.4.24.23 matrilysin macrophage primary, monocyte-derived 709345 3.4.24.34 neutrophil collagenase macrophage - -, 754754 3.4.24.35 gelatinase B macrophage - -, 684007, 707043, 708724, 709413, 709572, 709950, 733303, 733959 3.4.24.35 gelatinase B macrophage activated, MMP-9 secretion -, 683733 3.4.24.35 gelatinase B macrophage located within the granulation tissue 718355 3.4.24.35 gelatinase B macrophage macrophages contribute significantly to the elevated levels of MMP-9 in dystrophic muscle 708653 3.4.24.35 gelatinase B macrophage macrophages derived from THP-1 cells 707654 3.4.24.35 gelatinase B macrophage polymorphonuclear macrophages 700539 3.4.24.35 gelatinase B macrophage secretion of MMP-9 in the early phase of peritonitis, no MMP-9 production in unstimulated macrophages -, 683525 3.4.24.35 gelatinase B macrophage secretion of MMP-9, transcription factor NF-kappaB is important in MMP gene regulation in macrophage cells 683749 3.4.24.63 meprin B macrophage bone marrow-derived -, 753536 3.4.24.63 meprin B macrophage cortical and medullary macrophages of lymph node 669708 3.4.24.63 meprin B macrophage from primary human peripheral blood 733979 3.4.24.65 macrophage elastase macrophage - -, 668953, 671345, 683327, 708303, 708422, 754337, 754734, 754996 3.4.24.65 macrophage elastase macrophage alveolar -, 683054, 708452, 709559, 752886 3.4.24.65 macrophage elastase macrophage alveolar macrophages 31412, 683217 3.4.24.65 macrophage elastase macrophage MMP-12 is secreted by macrophages at sites of inflammation 683781 3.4.24.65 macrophage elastase macrophage MMP12 is an enzyme predominantly expressed in mature tissue macrophages 710050 3.4.24.65 macrophage elastase macrophage serum-free culture medium conditioned by thioglycollate-elicited peritoneal exudative macrophages 31410 3.4.24.65 macrophage elastase macrophage specific for 671345 3.4.24.65 macrophage elastase macrophage tissue culture medium of colchicin-treated inflammatory peritoneal macrophages 31409 3.4.24.7 interstitial collagenase macrophage primary, monocyte-derived 709345 3.4.24.71 endothelin-converting enzyme 1 macrophage from blood, determination of enzyme expression by immunohistochemical analysis using a combination of ECE-1 isoform-specific antibodies, expression of isozymes ECE-1a and ECE-1c 683440 3.4.24.82 ADAMTS-4 endopeptidase macrophage - 677894, 679302 3.4.24.86 ADAM 17 endopeptidase macrophage - 638980, 639001, 639002, 639013, 681031 3.4.24.B11 ADAMTS1 endopeptidase macrophage - 669350, 755146 3.4.24.B11 ADAMTS1 endopeptidase macrophage macrophages at sites of muscle injury induce activation of satellite cells via expression of Adamts1 754846 3.4.24.B28 ADAM15 macrophage - 733818 3.4.24.B5 matrix metalloproteinase-15 macrophage small expression 669713 3.4.24.B7 matrix metalloproteinase-26 macrophage - 686591 3.4.24.B7 matrix metalloproteinase-26 macrophage matrix metalloproteinase-26 is associated with macrophages and polymorphonuclear leukocytes 668149 3.4.24.B9 ADAM9 endopeptidase macrophage in advanced human atherosclerotic plaques of aorta and carotid and femoral arteries, high expression level 710868 3.5.1.15 aspartoacylase macrophage resident peritoneal 734393 3.5.1.2 glutaminase macrophage - 688502, 688517, 699661 3.5.1.60 N-(long-chain-acyl)ethanolamine deacylase macrophage - -, 734845, 752354, 754356 3.5.1.98 histone deacetylase macrophage - 678911 3.5.1.99 fatty acid amide hydrolase macrophage - 690846 3.5.3.1 arginase macrophage - 684384, 688998, 689301 3.5.3.1 arginase macrophage alveolar macrophage 667160, 686562 3.5.3.1 arginase macrophage cultured head-kidney derived macrophages, significant enzyme activity, inhibitable by Nomega-hydroxy-L-arginine and induced by dibutyryl cyclic adenosine 670294 3.5.3.1 arginase macrophage cultured head-kidney derived macrophages, significant enzyme activity, inhibitable by Nomega-hydroxy-L-arginine, not inducible by dibutyryl cyclic adenosine 670294 3.5.3.1 arginase macrophage type I 701646 3.5.3.15 protein-arginine deiminase macrophage - 666904, 711811 3.5.3.15 protein-arginine deiminase macrophage peptidylarginine deiminase 2, cell from patients with rheumatoid arthitis and healthy controls show identical expression patterns 663635 3.5.3.15 protein-arginine deiminase macrophage peritoneal 209428 3.5.3.18 dimethylargininase macrophage - 288973 3.5.4.37 double-stranded RNA adenine deaminase macrophage - 735124 3.5.4.38 single-stranded DNA cytosine deaminase macrophage - 754831 3.6.1.2 trimetaphosphatase macrophage - 209932 3.6.1.5 apyrase macrophage - -, 756375 3.6.1.6 nucleoside diphosphate phosphatase macrophage - 711898 3.6.1.6 nucleoside diphosphate phosphatase macrophage interstitial, NTPDase1 698165 3.6.4.13 RNA helicase macrophage - 758198 3.6.5.2 small monomeric GTPase macrophage - -, 734361, 735277 3.6.5.2 small monomeric GTPase macrophage TLRs agonists induce changes in the expression of Rap2a in macrophages. In contrast to mRNA levels, Rap2a protein levels are increased after LPS treatments of macrophages 757678 3.6.5.5 dynamin GTPase macrophage - 699347 4.1.1.17 ornithine decarboxylase macrophage - 708244 4.1.1.17 ornithine decarboxylase macrophage bone-marrow-derived macrophages 749189 4.1.1.17 ornithine decarboxylase macrophage M1 and M2 macrophages 747449 4.1.1.17 ornithine decarboxylase macrophage M1 and M2 macrophages, human colonic macrophages express increased ODC levels in active ulcerative colitis and Crohn's disease, colitis-associated dysplasia, and colitis-associated carcinogenesis 747449 4.1.1.22 histidine decarboxylase macrophage - 690778 4.1.1.28 aromatic-L-amino-acid decarboxylase macrophage - 705269 4.1.1.6 cis-aconitate decarboxylase macrophage - 723665 4.1.1.9 malonyl-CoA decarboxylase macrophage peritoneal 726656 4.2.99.18 DNA-(apurinic or apyrimidinic site) lyase macrophage - 701749 4.2.99.18 DNA-(apurinic or apyrimidinic site) lyase macrophage human peripheral macrophages 692549 4.4.1.1 cystathionine gamma-lyase macrophage - 708059 4.4.1.20 leukotriene-C4 synthase macrophage co-localization for 5-lipoxygenase activating protein, LTC4 synthase, cyclooxygenase-1 and prostaglandin D2 synthase in nasal biopsies. 10-43% of LTC4 synthase-positive cells being macrophages in perennial and seasonal allergic rhinitis biopsies. In the rhinitic biopsies, LTC4 synthase is detectable in 6-76% of macrophages 708181 4.4.1.5 lactoylglutathione lyase macrophage - 729179 4.6.1.2 guanylate cyclase macrophage alveolar 691072 5.3.2.1 phenylpyruvate tautomerase macrophage - 703331 5.3.3.12 L-dopachrome isomerase macrophage - 703331, 705691, 727347 5.3.99.2 Prostaglandin-D synthase macrophage - 747984 5.3.99.2 Prostaglandin-D synthase macrophage bone-marrow derived macrophage, lung and alveolar macrophage. Treatment with Escherichia coli lipopolysaccharide or Pseudomonas induce enzyme expression. Induction is regulated positively by AP-1 and negatively by p53 681206 5.3.99.2 Prostaglandin-D synthase macrophage of gut mucosa 679038 5.6.1.3 plus-end-directed kinesin ATPase macrophage - 670212 5.6.1.4 minus-end-directed kinesin ATPase macrophage - 210568 5.6.1.6 channel-conductance-controlling ATPase macrophage peritoneal 700104 5.6.2.2 DNA topoisomerase (ATP-hydrolysing) macrophage - 679700 6.1.1.15 proline-tRNA ligase macrophage - -, 745867 6.1.1.17 glutamate-tRNA ligase macrophage - -, 745867 6.1.1.2 tryptophan-tRNA ligase macrophage - -, 745868 6.1.1.6 lysine-tRNA ligase macrophage - 745539 6.2.1.3 long-chain-fatty-acid-CoA ligase macrophage peritoneal 692792 6.3.2.2 glutamate-cysteine ligase macrophage - 649263, 690677, 745805 7.1.1.2 NADH:ubiquinone reductase (H+-translocating) macrophage - 742878 7.1.1.9 cytochrome-c oxidase macrophage - 658633 7.1.2.2 H+-transporting two-sector ATPase macrophage - 686272 7.2.1.3 ascorbate ferrireductase (transmembrane) macrophage - 744757 7.2.2.9 P-type Cu2+ transporter macrophage - 712400